SCHEMBL9713839

SCHEMBL9713839

O=C(Oc1cc(Oc2ccccc2)c(OC(=O)c2ccccc2)c2ccc(Cl)cc12)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 6/20 0.46
POLB P06746 3/20 0.46
MRGPRX4 Q96LA9 1/20 0.43
MAPK1 P28482 1/20 0.42
LMNA P02545 5/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
PNLIP P16233 1/20 0.39
MAPT P10636 5/20 0.39
KMT2A Q03164 4/20 0.39
GAA P10253 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
MEN1 O00255 2/20 0.38
JAK2 O60674 1/20 0.38
USP2 O75604 1/20 0.38
ESR1 P03372 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9627668 0.87 KMT2A (0.50) POLBLMNASMN1; SMN2MAPTKMT2A
SCHEMBL9643247 0.84 ABCB11 (0.47) L3MBTL1POLBMRGPRX4MAPK1LMNA
SCHEMBL9713245 0.84 ABCB11 (0.53) L3MBTL1POLBMRGPRX4LMNASMN1; SMN2
SCHEMBL10502679 0.81 ABCB11 (0.46) L3MBTL1POLBLMNASMN1; SMN2CYP2C9
SCHEMBL29372079 0.80 ABCB11 (0.49) POLBLMNASMN1; SMN2MAPTKMT2A
SCHEMBL9713437 0.78 PDE7A (0.40) L3MBTL1POLBMAPK1LMNASMN1; SMN2
SCHEMBL9656747 0.78 KMT2A (0.42) L3MBTL1POLBMAPK1CYP1A2CYP3A4
SCHEMBL9658254 0.77 ALDH1A1 (0.48) L3MBTL1CYP1A2CYP2C9CYP2C19GAA
SCHEMBL9713650 0.76 SMN1; SMN2 (0.41) L3MBTL1LMNASMN1; SMN2MAPTKMT2A
SCHEMBL9643206 0.76 ABCB11 (0.44) POLBMRGPRX4LMNASMN1; SMN2PNLIP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5091558-A Topical administeration SYNTEX (U.S.A.) INC. (US) 1992-02-25 US disclosed
EP-0150831-B1 NAPHTHALENE ANTI-PSORIATIC AGENTS SYNTEX (U.S.A.) INC. (US) 1988-08-10 EP disclosed
EP-0150831-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1985-08-07 EP disclosed